» Articles » PMID: 19361613

Genetic Control of Human Brain Transcript Expression in Alzheimer Disease

Abstract

We recently surveyed the relationship between the human brain transcriptome and genome in a series of neuropathologically normal postmortem samples. We have now analyzed additional samples with a confirmed pathologic diagnosis of late-onset Alzheimer disease (LOAD; final n = 188 controls, 176 cases). Nine percent of the cortical transcripts that we analyzed had expression profiles correlated with their genotypes in the combined cohort, and approximately 5% of transcripts had SNP-transcript relationships that could distinguish LOAD samples. Two of these transcripts have been previously implicated in LOAD candidate-gene SNP-expression screens. This study shows how the relationship between common inherited genetic variants and brain transcript expression can be used in the study of human brain disorders. We suggest that studying the transcriptome as a quantitative endo-phenotype has greater power for discovering risk SNPs influencing expression than the use of discrete diagnostic categories such as presence or absence of disease.

Citing Articles

Zipper-interacting protein kinase mediates neuronal cell death and cognitive dysfunction in traumatic brain injury via regulating DEDD.

Mei Y, She F, Zhang L, Kim G, Li R, Zheng X Cell Death Dis. 2025; 16(1):151.

PMID: 40032841 PMC: 11876612. DOI: 10.1038/s41419-025-07474-7.


Transcriptomics and Proteomics Analysis of the Liver of Knockout Mice.

Song Y, Yang L, Han Y, Li W, Wei T, Gao Y Int J Mol Sci. 2025; 26(1.

PMID: 39796194 PMC: 11720713. DOI: 10.3390/ijms26010339.


The WAVE complex in developmental and adulthood brain disorders.

Kim H, Berdasco C, Nairn A, Kim Y Exp Mol Med. 2025; 57(1):13-29.

PMID: 39774290 PMC: 11799376. DOI: 10.1038/s12276-024-01386-w.


Transcription Factor-Wide Association Studies to Identify Functional SNPs in Alzheimer's Disease.

Dunn J, Moore C, Kim N, Gao T, Cheng Z, Jin P J Neurosci. 2024; 45(2.

PMID: 39622643 PMC: 11714347. DOI: 10.1523/JNEUROSCI.1800-24.2024.


Capturing biomarkers associated with Alzheimer disease subtypes using data distribution characteristics.

Smith K, Climer S Front Comput Neurosci. 2024; 18:1388504.

PMID: 39309755 PMC: 11413970. DOI: 10.3389/fncom.2024.1388504.


References
1.
Myers A, Pittman A, Zhao A, Rohrer K, Kaleem M, Marlowe L . The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis. 2006; 25(3):561-70. DOI: 10.1016/j.nbd.2006.10.018. View

2.
Kauwe J, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P . Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition. Proc Natl Acad Sci U S A. 2008; 105(23):8050-4. PMC: 2430357. DOI: 10.1073/pnas.0801227105. View

3.
Lambert J, Goumidi L, Vrieze F, Frigard B, Harris J, Cummings A . The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet. 2000; 9(15):2275-80. DOI: 10.1093/oxfordjournals.hmg.a018918. View

4.
Schliekelman P . Statistical power of expression quantitative trait loci for mapping of complex trait loci in natural populations. Genetics. 2008; 178(4):2201-16. PMC: 2323809. DOI: 10.1534/genetics.107.076687. View

5.
Workman C, Jensen L, Jarmer H, Berka R, Gautier L, Nielser H . A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol. 2002; 3(9):research0048. PMC: 126873. DOI: 10.1186/gb-2002-3-9-research0048. View